Total Voting Rights
Oxford Biomedica PLC announced that as of March 31, 2026, its issued share capital consists of 120,900,850 ordinary shares, with no shares held in treasury, resulting in a total of 120,900,850 voting rights. This figure serves as the denominator for shareholders to determine their notification obligations under the FCA's Disclosure Guidance and Transparency Rules regarding their interests in the company.
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
Oxford, UK - 01 April 2026: OXB (LSE: OXB) (the "Company"), a global quality and innovation-led cell and gene therapy CDMO, today announces that in accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R, the Company's issued share capital as at the close of business on 31 March 2026 consisted of 120,900,850 ordinary shares of 50 pence each ("Ordinary Shares"). There are no Ordinary Shares held in treasury.
Accordingly, the total number of voting rights in OXB at the date of this notice is 120,900,850.
The above figure 120,900,850 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, OXB under the FCA's Disclosure Guidance and Transparency Rules.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.